Immunotherapy for cancer is a rapidly developing treatment that modifies the immune system
and enhances the antitumor immune response. B7-H3 (CD276), a member of the B7 family …

Glioblastoma (GBM) is the most malignant and lethal intracranial tumor, with extremely
limited treatment options. Immunotherapy has been widely studied in GBM, but none can …

Isolating high-quality RNA from latex of H. brasiliensis is a prerequisite to elucidating the
molecular mechanisms of rubber biosynthesis and its regulation. Here, an improved protocol …

The optimal treatment of recurrent glioblastoma (GBM) remains controversial. Therefore, our
study aimed to compare and rank active therapies in recurrent GBM. We performed a …

Glioblastoma (GBM) is the most malignant CNS tumor with a highest incidence rate, and
most patients would undergo a recurrence. Recurrent GBM (rGBM) shows an increasing …

Purpose The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT)
promoter has been proven to be a prognostic and predictive biomarker for lower grade glioma …

As one of bad smells in code, code clones may increase the cost of software maintenance
and the risk of vulnerability propagation. In the past two decades, numerous clone detection …

Preferable treatments for epidermal growth factor receptor (EGFR)-mutant non-small cell
lung cancer (NSCLC) with brain metastasis are elusive. The study intended to estimate the …

Introduction Glioblastoma multiforme (GBM) is the most common primary central nervous (CNS)
system malignancy with a poor prognosis. The standard treatment for GBM is …

Background Most patients with glioma experience recurrence and have a poor prognosis.
Scientometric analysis is effective and widely used to summarize the most influential studies …